GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Resonance Health Ltd (ASX:RHT) » Definitions » Equity-to-Asset

Resonance Health (ASX:RHT) Equity-to-Asset : 0.54 (As of Jun. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Resonance Health Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Resonance Health's Total Stockholders Equity for the quarter that ended in Jun. 2024 was A$10.93 Mil. Resonance Health's Total Assets for the quarter that ended in Jun. 2024 was A$20.28 Mil. Therefore, Resonance Health's Equity to Asset Ratio for the quarter that ended in Jun. 2024 was 0.54.

The historical rank and industry rank for Resonance Health's Equity-to-Asset or its related term are showing as below:

ASX:RHT' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.54   Med: 0.89   Max: 0.95
Current: 0.54

During the past 13 years, the highest Equity to Asset Ratio of Resonance Health was 0.95. The lowest was 0.54. And the median was 0.89.

ASX:RHT's Equity-to-Asset is ranked better than
58.41% of 690 companies
in the Healthcare Providers & Services industry
Industry Median: 0.49 vs ASX:RHT: 0.54

Resonance Health Equity-to-Asset Historical Data

The historical data trend for Resonance Health's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonance Health Equity-to-Asset Chart

Resonance Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 0.95 0.92 0.91 0.54

Resonance Health Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 0.89 0.91 0.90 0.54

Competitive Comparison of Resonance Health's Equity-to-Asset

For the Health Information Services subindustry, Resonance Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Resonance Health's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Resonance Health's Equity-to-Asset falls into.



Resonance Health Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Resonance Health's Equity to Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Equity to Asset (A: Jun. 2024 )=Total Stockholders Equity/Total Assets
=10.932/20.283
=0.54

Resonance Health's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=10.932/20.283
=0.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Resonance Health  (ASX:RHT) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Resonance Health Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Resonance Health's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Resonance Health Business Description

Traded in Other Exchanges
N/A
Address
141-143 Burswood Road, Level 1, Burswood, Perth, WA, AUS, 6100
Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, Cardiac T2, and HepaFat-Scan. It also has several AI-assisted SaMDs including FerriSmart, HepaFat-AI, and LiverSmart. The company's business segments are; Services which derives key revenue, Research and development, Corporate, Clinical Research Organization (CRO), and TrialsWest. Geographically, it generates maximum revenue from the Asia Pacific and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.

Resonance Health Headlines

No Headlines